Comparison of autologous cell therapy and granulocyte-colony stimulating factor (G-CSF) injection vs. G-CSF injection alone for the treatment of acute radiation syndrome in a non-human primate model

  • La recherche

  • Recherche

01/11/2005

Titre de la revue : International Journal of Radiation Oncology, Biology, Physics Volume : 63 N° : 3 Pagination : 911-920 Date de publication : 01/11/2005

Type de document > *Article de revue
Unité de recherche > IRSN/DRPH/SRBE/LRTOX
Auteurs > BERTHO Jean-Marc , DEMARQUAY Christelle , DUDOIGNON Nicolas , FRICK Johanna , GORIN Norbert Claude , GOURMELON Patrick , PRAT Marie , THIERRY Dominique , TROMPIER François

To compare the efficacy of autologous cell therapy after irradiation combined with granulocyte-colony stimulating factor (G-CSF) injections with G-CSF treatment alone in a heterogeneous model of irradiation representative of an accidental situation. Material and Methods: Non-human primates were irradiated at 8.7 Gy whole-body dose with the right arm shielded to receive 4.8 Gy. The first group of animals received G-CSF (lenograstim) injections starting 6 h after irradiation, and a second group received a combination of G-CSF (lenograstim) injections and autologous expanded hematopoietic cells. Animals were followed up for blood cell counts, circulating progenitors, and bone marrow cellularity. Results: No significant differences were seen between the two treatment groups, whatever the parameter observed: time to leukocyte or platelet recovery and duration and severity of aplasia. Conclusion: Our results indicated that identical recovery kinetic was observed when irradiated animals are treated with G-CSF independently of the reinjection of ex vivo expanded autologous hematopoietic cells. Thus G-CSF injections might be chosen as a first-line therapeutic strategy in the treatment of accidental acute radiation victims.

Migration content title
En savoir plus
Migration content title
Text complet
Migration content text